InvestMaryland chair takes CEO position with Mass.-based biotech firm

Peter Greenleaf flanked by Governor O'Malley and Christian Johansson, former chief of the Department of Business and Economic Development.

Peter Greenleaf, chair of the board overseeing the $84 million InvestMaryland venture fund, is taking a CEO job with Massachusetts-based biotech company Histogenics.
Greenleaf, former president of MedImmune in Gaithersburg, will remain chairman of the InvestMaryland board, a four-year position, at the request of Governor Martin O’Malley.
Read more here.

Subscribe to our Newsletters
Technically Media
Connect with companies from the community
New call-to-action